Lawsuits regarding Actos have started going to trial alleging the diabetes drug causes bladder cancer and that Takeda Pharmaceuticals was aware. We have blogged before about Actos and after a jury in Louisiana awarded over 9 billion dollars in punitive damages it is time to blog about this issue again.
Actos for diabetes? Bladder Cancer?
Actos for diabetes? Bladder Cancer? Many people who previously took the drug Actos for their diabetes and were disagnosed with Bladder Cancer are finding out that the FDA became aware of a statistical correlation.
Actos (Pioglitazone): Bladder Cancer Risk
Bladder Cancer Risk from Actos (pioglitazone). On June 15, 2011 the U.S. Food and Drug Administration (FDA) announced that use of the diabetes medication Actos (pioglitazone) for more than one year may be associated with an increased risk of bladder cancer.
